Abstract
Three myelopoietically active, lipopolysaccharide (LPS)-stimulated monokines, interleukin-1 alpha (IL-1 alpha), tumor necrosis factor alpha (TNF-alpha), and leukemia inhibitory factor (LIF), were tested for effect in an in vitro model for LPS-induced inflammatory murine monocytopoiesis. Neither cytokine stimulated clonal proliferation of marrow-derived progenitors; however, both IL-1 alpha and TNF-alpha enhanced macrophage colony-stimulating factor (M-CSF)-dependent colony formation. The additional progenitors stimulated by IL-1 alpha and TNF-alpha to form colonies in response to M-CSF were equivalent to the precommitment, transitional progenitors stimulated by M-CSF and bacterial LPS. In addition, the additional colonies elicited by IL-1 alpha and TNF-alpha were not additive in cultures containing both M-CSF and LPS, indicating these colonies arose from the same LPS-responsive, two-signal-dependent transitional progenitors. Leukemia inhibitory factor did not influence M-CSF-stimulated colony formation; however, LIF effected a dose-dependent inhibition of colony formation by transitional progenitors responding to combinations of M-CSF and LPS, IL-1 alpha, TNF-alpha, or an additional transitional cell costimulant, substance P. Neutralizing anti-murine TNF-alpha antibodies abrogated transitional cell colony formation stimulated by combinations of M-CSF and TNF-alpha, IL-1 alpha, LPS, or substance P but had no effect on colony formation stimulated solely by M-CSF. The results indicate that TNF-alpha may be an important positive stimulus for commitment of progenitors to the mononuclear phagocyte lineage and that TNF-alpha may be the endogenous regulator of the costimulatory effects of LPS, IL-1, and substance P. In addition, the results indicate that LIF may play an opposing negative regulatory role acting to inhibit LPS and TNF-alpha stimulation of the transitional progenitors.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Baumann H., Wong G. G. Hepatocyte-stimulating factor III shares structural and functional identity with leukemia-inhibitory factor. J Immunol. 1989 Aug 15;143(4):1163–1167. [PubMed] [Google Scholar]
- Broxmeyer H. E., Cooper S., Levi S., Arosio P. Mutated recombinant human heavy-chain ferritins and myelosuppression in vitro and in vivo: a link between ferritin ferroxidase activity and biological function. Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):770–774. doi: 10.1073/pnas.88.3.770. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Broxmeyer H. E., Sherry B., Cooper S., Ruscetti F. W., Williams D. E., Arosio P., Kwon B. S., Cerami A. Macrophage inflammatory protein (MIP)-1 beta abrogates the capacity of MIP-1 alpha to suppress myeloid progenitor cell growth. J Immunol. 1991 Oct 15;147(8):2586–2594. [PubMed] [Google Scholar]
- Broxmeyer H. E., Williams D. E., Lu L., Cooper S., Anderson S. L., Beyer G. S., Hoffman R., Rubin B. Y. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma. J Immunol. 1986 Jun 15;136(12):4487–4495. [PubMed] [Google Scholar]
- Brugger W., Rosenthal F. M., Kanz L., Mertelsmann R. Clinical role of colony stimulating factors. Acta Haematol. 1991;86(3):138–147. doi: 10.1159/000204823. [DOI] [PubMed] [Google Scholar]
- Caux C., Saeland S., Favre C., Duvert V., Mannoni P., Banchereau J. Tumor necrosis factor-alpha strongly potentiates interleukin-3 and granulocyte-macrophage colony-stimulating factor-induced proliferation of human CD34+ hematopoietic progenitor cells. Blood. 1990 Jun 15;75(12):2292–2298. [PubMed] [Google Scholar]
- Detrick M. S., Kreisberg R., Koontz J. W., Moore R. N. Nanomolar cyclic adenosine and guanosine monophosphates stimulate macrophage colony-stimulating factor responsiveness by murine transitional progenitors. J Leukoc Biol. 1992 Sep;52(3):249–254. doi: 10.1002/jlb.52.3.249. [DOI] [PubMed] [Google Scholar]
- Dinarello C. A. Inflammatory cytokines: interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases. Curr Opin Immunol. 1991 Dec;3(6):941–948. doi: 10.1016/s0952-7915(05)80018-4. [DOI] [PubMed] [Google Scholar]
- Duma E. M., Foster J. S., Moore R. N. Bradykinin sensitization of CSF-1-responsive murine mononuclear phagocyte precursors to prostaglandin E. J Immunol. 1988 Nov 1;141(9):3186–3189. [PubMed] [Google Scholar]
- Gasparetto C., Laver J., Abboud M., Gillio A., Smith C., O'Reilly R. J., Moore M. A. Effects of interleukin-1 on hematopoietic progenitors: evidence of stimulatory and inhibitory activities in a primate model. Blood. 1989 Aug 1;74(2):547–550. [PubMed] [Google Scholar]
- Goldman R., Bar-Shavit Z. On the mechanism of the augmentation of the phagocytic capability of phagocytic cells by Tuftsin, substance P, neurotensin, and kentsin and the interrelationship between their receptors. Ann N Y Acad Sci. 1983;419:143–155. doi: 10.1111/j.1749-6632.1983.tb37099.x. [DOI] [PubMed] [Google Scholar]
- Grolleau D., Soulillou J. P., Anegon I. Control of HILDA/LIF gene expression in activated human monocytes. Ann N Y Acad Sci. 1991;628:19–30. doi: 10.1111/j.1749-6632.1991.tb17219.x. [DOI] [PubMed] [Google Scholar]
- Hilton D. J. LIF: lots of interesting functions. Trends Biochem Sci. 1992 Feb;17(2):72–76. doi: 10.1016/0968-0004(92)90505-4. [DOI] [PubMed] [Google Scholar]
- Hilton D. J., Nicola N. A., Metcalf D. Specific binding of murine leukemia inhibitory factor to normal and leukemic monocytic cells. Proc Natl Acad Sci U S A. 1988 Aug;85(16):5971–5975. doi: 10.1073/pnas.85.16.5971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Janckila A. J., Gentile P. S., Yam L. T. Hemopoietic inhibition in hairy cell leukemia. Am J Hematol. 1991 Sep;38(1):30–39. doi: 10.1002/ajh.2830380106. [DOI] [PubMed] [Google Scholar]
- Kobari L., Weil D., Lemoine F. M., Dubois C., Thiam D., Baillou C., Guigon M., Gorin N. C., Najman A. Secretion of tumor necrosis factor-alpha by fresh human acute nonlymphoblastic leukemic cells: role in the disappearance of normal CFU-GM progenitors. Exp Hematol. 1990 Dec;18(11):1187–1192. [PubMed] [Google Scholar]
- Metcalf D., Hilton D. J., Nicola N. A. Clonal analysis of the actions of the murine leukemia inhibitory factor on leukemic and normal murine hemopoietic cells. Leukemia. 1988 Apr;2(4):216–221. [PubMed] [Google Scholar]
- Moore R. N., Duma E. M., Bowersock T. L. Bradykinin sensitization of colony-stimulating factor-1-responsive murine marrow progenitors to prostaglandin E. A property of the amino-terminal tetrapeptide fragment. J Immunol. 1990 Jan 15;144(2):667–670. [PubMed] [Google Scholar]
- Moore R. N., Joshi J. G., Deana D. G., Pitruzzello F. J., Horohov D. W., Rouse B. T. Characterization of a two-signal-dependent, Ia+ mononuclear phagocyte progenitor subpopulation that is sensitive to inhibition by ferritin. J Immunol. 1986 Mar 1;136(5):1605–1611. [PubMed] [Google Scholar]
- Moore R. N., Osmand A. P., Dunn J. A., Joshi J. G., Koontz J. W., Rouse B. T. Neurotensin regulation of macrophage colony-stimulating factor-stimulated in vitro myelopoiesis. J Immunol. 1989 Apr 15;142(8):2689–2694. [PubMed] [Google Scholar]
- Moore R. N., Osmand A. P., Dunn J. A., Joshi J. G., Rouse B. T. Substance P augmentation of CSF-1-stimulated in vitro myelopoiesis. A two-signal progenitor restricted, tuftsin-like effect. J Immunol. 1988 Oct 15;141(8):2699–2703. [PubMed] [Google Scholar]
- Mori M., Yamaguchi K., Abe K. Purification of a lipoprotein lipase-inhibiting protein produced by a melanoma cell line associated with cancer cachexia. Biochem Biophys Res Commun. 1989 May 15;160(3):1085–1092. doi: 10.1016/s0006-291x(89)80114-7. [DOI] [PubMed] [Google Scholar]
- Muench M. O., Schneider J. G., Moore M. A. Interactions among colony-stimulating factors, IL-1 beta, IL-6, and kit-ligand in the regulation of primitive murine hematopoietic cells. Exp Hematol. 1992 Mar;20(3):339–349. [PubMed] [Google Scholar]
- Munker R., DiPersio J., Koeffler H. P. Tumor necrosis factor: receptors on hematopoietic cells. Blood. 1987 Dec;70(6):1730–1734. [PubMed] [Google Scholar]
- Murphy M., Perussia B., Trinchieri G. Effects of recombinant tumor necrosis factor, lymphotoxin, and immune interferon on proliferation and differentiation of enriched hematopoietic precursor cells. Exp Hematol. 1988 Feb;16(2):131–138. [PubMed] [Google Scholar]
- Pease S., Braghetta P., Gearing D., Grail D., Williams R. L. Isolation of embryonic stem (ES) cells in media supplemented with recombinant leukemia inhibitory factor (LIF). Dev Biol. 1990 Oct;141(2):344–352. doi: 10.1016/0012-1606(90)90390-5. [DOI] [PubMed] [Google Scholar]
- Pelus L. M., Ottmann O. G., Nocka K. H. Synergistic inhibition of human marrow granulocyte-macrophage progenitor cells by prostaglandin E and recombinant interferon-alpha, -beta, and -gamma and an effect mediated by tumor necrosis factor. J Immunol. 1988 Jan 15;140(2):479–484. [PubMed] [Google Scholar]
- Piacibello W., Sanavio F., Severino A., Morelli S., Vaira A. M., Stacchini A., Aglietta M. Opposite effect of tumor necrosis factor alpha on granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor-dependent growth of normal and leukemic hemopoietic progenitors. Cancer Res. 1990 Aug 15;50(16):5065–5071. [PubMed] [Google Scholar]
- Reid L. R., Lowe C., Cornish J., Skinner S. J., Hilton D. J., Willson T. A., Gearing D. P., Martin T. J. Leukemia inhibitory factor: a novel bone-active cytokine. Endocrinology. 1990 Mar;126(3):1416–1420. doi: 10.1210/endo-126-3-1416. [DOI] [PubMed] [Google Scholar]
- Waheed A., Shadduck R. K. Purification and properties of L cell-derived colony-stimulating factor. J Lab Clin Med. 1979 Jul;94(1):180–193. [PubMed] [Google Scholar]
- Williams R. L., Hilton D. J., Pease S., Willson T. A., Stewart C. L., Gearing D. P., Wagner E. F., Metcalf D., Nicola N. A., Gough N. M. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature. 1988 Dec 15;336(6200):684–687. doi: 10.1038/336684a0. [DOI] [PubMed] [Google Scholar]
- Yamamori T., Fukada K., Aebersold R., Korsching S., Fann M. J., Patterson P. H. The cholinergic neuronal differentiation factor from heart cells is identical to leukemia inhibitory factor. Science. 1989 Dec 15;246(4936):1412–1416. doi: 10.1126/science.2512641. [DOI] [PubMed] [Google Scholar]
